Search Immortality Topics:

Page 7«..6789..2030..»


Category Archives: Global News Feed

Imugene’s oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024

SYDNEY, Australia, April 09, 2024 (GLOBE NEWSWIRE) -- Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company, is pleased to announce poster presentations featuring its CF33 oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx at the American Association for Cancer Research (AACR) Annual Meeting 5-10 April 2024, in San Diego, CA.

Visit link:
Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024

Posted in Global News Feed | Comments Off on Imugene’s oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024

IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103

Non-Clinical Poster Data Support the Use of Dual Antigen Approach to Enhance Anti-Tumor Activity Non-Clinical Poster Data Support the Use of Dual Antigen Approach to Enhance Anti-Tumor Activity

Visit link:
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103

Posted in Global News Feed | Comments Off on IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103

EUROAPI streamlines its Executive Committee to improve focus and efficiency

Paris – April 9, 2024 – EUROAPI today announces a streamlining of its Executive Committee around operational functions in order to improve focus and efficiency. This organizational adjustment is part of the transformation of EUROAPI into an innovative API supplier and CDMO with a unique, high-quality and customized product offering.

Follow this link:
EUROAPI streamlines its Executive Committee to improve focus and efficiency

Posted in Global News Feed | Comments Off on EUROAPI streamlines its Executive Committee to improve focus and efficiency

Inc.’s 2024 Female Founders list highlights why female founders are always a good bet

adyn founder, Elizabeth Ruzzo, named to the list adyn founder, Elizabeth Ruzzo, named to the list

Go here to read the rest:
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet

Posted in Global News Feed | Comments Off on Inc.’s 2024 Female Founders list highlights why female founders are always a good bet

Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results

Conference Call and Live Audio Webcast Scheduled for March 26, 2024 Conference Call and Live Audio Webcast Scheduled for March 26, 2024

Here is the original post:
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results

Posted in Global News Feed | Comments Off on Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results

New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia

REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), announced additional positive Phase 1b/2a data on briquilimab as a conditioning agent in the treatment of Fanconi Anemia (FA).

Continued here:
New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia

Posted in Global News Feed | Comments Off on New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia